№ lp_1_26669
File format: docx
Character count: 9011
File size: 107 KB
This Standard Operating Procedure outlines the processes for managing controlled documents used in clinical research at KSU, specifying responsibilities for document control, versioning, and review.
Year:
2026
Region / City:
KSU
Subject:
Clinical Research, Document Control
Document Type:
Standard Operating Procedure (SOP)
Organization / Institution:
KSU
Author:
Not specified
Target Audience:
Research staff, regulatory personnel, investigators
Period of Action:
Ongoing
Approval Date:
Not specified
Modification Date:
Not specified
Document Version:
Not specified
Confidential:
Yes
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2017
Region / City:
Kent State University
Subject:
Clinical Research
Document Type:
Standard Operating Procedure (SOP)
Institution:
Kent State University
Author:
Not specified
Target Audience:
Clinical research staff, Principal Investigators, Study Coordinators
Period of Validity:
Ongoing
Approval Date:
01/29/2017
Revision Date:
Not specified
Year:
2026
Institution:
Kennesaw State University
Council:
General Education Council (GEC)
Type:
Governance model and handbook update
Scope:
Undergraduate education
Purpose:
Oversight and coordination of general education curriculum
Membership:
Faculty and administrative representatives from undergraduate-serving colleges and departments
Term Length:
2–3 years with term limits
Meetings:
Monthly during the academic year, with additional executive committee meetings as needed
Departments Represented:
Anthropology, Art and Design, Molecular and Cellular Biology, Ecology, Evolution and Organismal Biology, Chemistry, Communication, Composition, Criminal Justice, Dance, Economics, Foreign Languages, Geography, History, Interdisciplinary Studies, Leadership and Integrative Studies, Literature, Mathematics, Music, Philosophy, Physics, Political Science, Psychology, Sociology, Statistics, Theatre and Performance Studies
Advisory Members:
Faculty Director of General Education, Associate Vice President for Curriculum, Curriculum Support Office Representative, SGA Representative, CDA Representative, Advising Representative
Note:
Year
Institution:
KSU School of Foreign Languages
Document Type:
Language Examination Paper
Exam Type:
English Proficiency / Placement Test
Target Audience:
Erasmus Students
Duration:
60 Minutes
Assessment Format:
Multiple Choice Questions and Reading Comprehension
Sections:
Vocabulary, Grammar, Translation, Sentence Completion, Reading Comprehension
Languages Present in Test:
English and Turkish
Answer Method:
Optical Answer Sheet
Topic Areas:
Language Skills, Grammar, Vocabulary, Translation, Reading Comprehension
Year:
Not specified
Region / City:
KSU
Topic:
Research Procedures
Document Type:
SOP (Standard Operating Procedure)
Institution:
KSU
Author:
Not specified
Target Audience:
Research Staff
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2018
Region / city:
Victoria, Australia
Theme:
Environmental Impact Assessment, Offshore Gas and Condensate Production
Document Type:
Environmental Plan Summary
Organization / institution:
Cooper Energy
Author:
Cooper Energy
Target Audience:
Stakeholders, Environmental Regulators, Industry Professionals
Effective Period:
Ongoing (Operations and Maintenance Phase)
Approval Date:
April 30, 2018
Revision Date:
April 30, 2018
Year:
2023
Location:
Atlanta, GA, USA
Document Type:
Working Instructions / Inventory Form
Regulatory Authority:
Drug Enforcement Administration (DEA)
Author:
Joe Smith
Intended Audience:
DEA Registrants and laboratory staff
Inventory Scope:
Schedule I – II and Schedule III – V Controlled Substances
Inventory Date:
05/01/23
Inventory Time:
Beginning of Business (BOB) / Close of Business (COB)
Employees Conducting Inventory:
Joe Smith, Joann Taylor
Year:
2023
Region / City:
Atlanta, GA
Topic:
Controlled Substances Receiving Log
Document Type:
Instructional Form
Organization:
DEA
Author:
Not specified
Target Audience:
Registrants with DEA License
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Note:
Department
Year:
2024
Region / City:
N/A
Topic:
Critical Appraisal
Document Type:
Checklist
Organization / Institution:
Critical Appraisal Skills Programme (CASP)
Author:
Critical Appraisal Skills Programme (CASP)
Target Audience:
Healthcare professionals, researchers
Date of Approval:
N/A
Date of Modification:
N/A
Year:
Not specified
Organization:
University of Washington
Document Type:
System Security Plan
Audience:
Internal staff handling FCI and CUI
Scope:
Federal Contract Information (FCI) and Controlled Unclassified Information (CUI)
Sections Included:
Environment Profile, Environment and Assets, Access Control Practices
Technical Controls:
ASTRA Access Management, Active Directory, Azure AD, Husky OnNet VPN, DUO 2-Factor Authentication, Kerberos, LDAP, UW Groups, UW NetID, Web SSO
Procedures:
User access management, device approval, external connection controls, public information control
Year:
2023
Region:
Scotland
Jurisdiction:
Scotland
Topic:
Management of controlled drugs in primary care
Document type:
Guidance
Version:
3.0
Publication date:
April 2023
Issuing body:
Controlled Drugs Accountable Officers’ Network Scotland
Contributing organisation:
NHS Dumfries & Galloway
Foreword author:
Graeme Bryson
Author role:
Director of Pharmacy
Target audience:
Practitioners working within primary care
Legal framework referenced:
Misuse of Drugs Act 1971; Misuse of Drugs Regulations 2001; Controlled Drugs (Supervision of Management and Use) Regulations 2013
Scope:
Prescribing, supply, administration, storage, recording, monitoring and destruction of controlled drugs
Source type:
Official professional guidance
Note:
Year
Topic:
Incident Reporting
Document Type:
Report Form
Organization:
NHS
Target Audience:
NHS Staff, Contractors
Protocol version:
6.0
Date:
18 September 2020
Study name:
rEECur
Study design:
International randomised controlled trial
Medical condition:
Recurrent and primary refractory Ewing sarcoma
Intervention:
Chemotherapy
Sponsor:
University of Birmingham
Sponsor protocol number:
RG_13-277
CRCTU number:
SA2015
EudraCT number:
2014-000259-99
ISRCTN reference number:
ISRCTN36453794
Chief Investigator:
Dr Martin McCabe
Coordinating institution:
Cancer Research UK Clinical Trials Unit, University of Birmingham
Geographic scope:
International
Participating regions:
United Kingdom, Germany, Italy, France, Spain, Scandinavia, Australia, New Zealand, Switzerland
Target population:
Patients with recurrent or primary refractory Ewing sarcoma
Regulatory status:
Ethics and regulatory approval required per participating country
Amendment history:
Substantial amendments between 2014 and 2016
Document type:
Clinical trial protocol
Randomisation method:
Centralised online randomisation
Trial phase:
Phase II (Germany-specific limitation noted)
Year:
2019
Region / City:
Not specified
Topic:
Regulatory Compliance, Banking
Document Type:
Application Form
Organization:
IFSCA
Author:
Not specified
Period of Validity:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2021
Region / city:
Not specified
Topic:
Randomised controlled trials, research appraisal
Document type:
Checklist
Organization / institution:
Critical Appraisal Skills Programme (CASP)
Author:
Not specified
Target audience:
Healthcare professionals, researchers, educators
Period of validity:
Not specified
Approval date:
Not specified
Date of revisions:
16 September 2020
Year:
2021
Region / City:
United States
Topic:
Health Care, COVID-19 Response
Document Type:
Template, Instructions
Organization:
HRSA (Health Resources and Services Administration)
Author:
HRSA
Target Audience:
Health Centers, Organizations Applying for Funding
Effective Period:
2021-2023
Approval Date:
N/A
Amendment Date:
N/A
Note:
Year
Subject:
Controlled Substances Loss or Theft
Document Type:
Form
Organization / Institution:
UTSA
Organization:
Joanna Briggs Institute (JBI)
Document type:
Critical appraisal tool / checklist
Topic:
Randomized controlled trials (RCTs)
Target audience:
Researchers conducting systematic reviews
Year:
2020
Source:
JBI Manual for Evidence Synthesis
Format:
Checklist for individual participants in parallel group RCTs
Purpose:
Assess methodological quality and risk of bias in RCTs
Reference:
Tufanaru C, Munn Z, Aromataris E, Campbell J, Hopp L. Chapter 3: Systematic reviews of effectiveness
Year:
2024
Region / City:
Controlled airspace
Subject:
UAS operations, air traffic service
Document Type:
Risk assessment and mitigation document
Organ / Institution:
ENAIRE
Author:
UAS Operator
Target Audience:
UAS Operators, Air Traffic Service Providers
Period of validity:
Until new operational risk assessment is required
Approval Date:
Not specified
Modification Date:
Not specified